Danone, Nestlé and Lactalis bet on meal replacements for growth

Meal replacements are turning into one of the clearest growth adjacencies in dairy, and the logic is easy to see once you look past the buzzwords. These products let big milk companies sell protein, satiety and convenience in one package, which is a much better business than fighting for pennies in plain-vanilla fluid milk. For Danone, Nestlé and Lactalis, the category is starting to look less like a fad and more like a practical route into premium nutrition.

Why meal replacements matter now

The attraction is not just higher protein. A meal replacement can bundle complete nutrition, portability and functional benefits, which gives it a tighter use case than a tub of yogurt or a carton of milk. That matters because consumers are increasingly eating around their schedules, not around the traditional meal calendar, and dairy has to meet them where they are.

It also changes the economics of the aisle. A brand positioned for breakfast replacement, post-workout recovery, on-the-go fueling or GLP-1 support can command more attention than a commodity dairy product ever will. That is the real portfolio story here: meal replacements help dairy majors monetize convenience and premium nutrition, while still leaning on the strengths they already own, especially protein quality and taste.

Danone is using Huel to deepen functional nutrition

Danone moved early and moved clearly. On March 23, 2026, the company announced a definitive agreement to acquire Huel, describing the business as a leader in complete, nutritionally balanced meal solutions. Danone said the deal would strengthen its presence in functional nutrition and extend it into the fast-growing Complete Nutrition space.

That makes strategic sense when you look at Danone’s own portfolio. The company reported FY 2025 sales of EUR 27.283 billion and said North America had sustained momentum in High Protein, a sign that it is already seeing demand for more protein-dense products. Huel gives Danone a more direct line into a category built around powders and ready-to-drink meals, supported by strong digital direct-to-consumer sales and a fan base across the UK, Europe and the US.

If you read this as a pure innovation play, that is only half the picture. Danone is also protecting itself against a world where consumers want less friction and more utility from every calorie they buy. The Huel deal lets the company buy speed in a segment where building credibility from scratch would take too long.

Nestlé is buying scale in smart food

Nestlé’s move into yfood follows the same logic, but with a sharper emphasis on reach. On June 3, 2026, Nestlé said it would fully acquire yfood Labs GmbH after holding a 49% stake since 2023. Nestlé described yfood as one of Europe’s leading smart food brands and said its products are available in 30 countries and more than 50,000 points of sale.

The numbers help explain why that asset mattered. Nestlé said yfood generated about EUR 150 million in sales in 2025 and grew at a double-digit rate. In other words, this is not a speculative bet on a niche format, it is a scaled business with evidence of repeat demand and international distribution.

Nestlé’s interest also fits the broader direction of its portfolio, which has increasingly favored faster-growing nutrition brands. yfood gives it a ready-made position in ready-to-drink meals, a segment that sits neatly between beverage convenience and meal functionality. That is the kind of bridge category a global food company can plug into retail, vending and on-the-go consumption without reinventing its manufacturing base.

Lactalis is pushing beyond core dairy

Lactalis joined the same race on June 1, 2026, when it finalized the acquisition of Protein Works. The UK-based company, founded in 2012 and headquartered in Liverpool, sells protein shakes, meal replacements, wellness supplements and snacks. It generates annual revenue of about EUR 65 million, which is small next to the giants buying it, but exactly the sort of specialized platform they want.

Lactalis said the deal strengthens its health and nutrition offering, and that is the key phrase. The company already has a clinical nutrition presence through Delical, so Protein Works is not a random side quest. It extends Lactalis deeper into active nutrition, where consumers are already accustomed to paying for performance, format convenience and functional claims.

That also shows how serious the larger dairy groups have become about category diversification. Lactalis describes itself as the world’s leading dairy group, and it is clearly using that scale to move into higher-value nutrition forms rather than relying only on traditional dairy throughput. Protein Works gives it a sharper position in meal replacements and sports-adjacent nutrition, both of which fit the new demand profile better than standard milk ever could.

The consumer shift is doing a lot of the work

The market backdrop is strong enough to make these acquisitions look rational, not defensive. One recent estimate puts the global meal replacement products market at USD 14.93 billion in 2025, rising to USD 27.74 billion by 2035. Another estimate pegs the market at USD 19.8 billion in 2025. Either way, the direction is the same: this is a large and growing category, not a novelty shelf.

The growth drivers are easy to identify. Busy lifestyles reward products that compress nutrition into a portable format, while weight management, low-sugar demand and high-protein preferences keep pushing consumers toward more functional choices. GLP-1 drugs such as Ozempic and Zepbound add another layer, because they are changing how people eat and how much they buy.

Cornell research found that households using GLP-1 drugs reduced grocery spending by an average of 5.3% within six months, while fast-food and coffee-shop spending fell by about 8%. That suggests a real shift in meal occasions, not just a short-term dieting spike. If consumers are buying fewer traditional meals and more targeted nutrition, meal replacements become a natural landing spot.

Innovation play or defensive hedge? It is both

The smartest read is that these deals are not mutually exclusive. They are innovation plays because they give dairy majors a way to participate in complete nutrition, active nutrition and medical-adjacent consumption patterns that conventional milk cannot capture on its own. But they are also defensive hedges, because they help those same companies stay relevant if traditional dairy consumption keeps fragmenting into smaller, more functional purchases.

That is why the segment matters so much for portfolio strategy. Danone, Nestlé and Lactalis are not just buying brands, they are buying a new way to package dairy’s natural advantages for modern routines. If meal replacements keep growing, the winners will be the companies that can combine protein, convenience and credibility without making the product feel like a compromise.